WO2010001408A3 - Novel polymorphic forms of gemifloxacin mesylate - Google Patents

Novel polymorphic forms of gemifloxacin mesylate Download PDF

Info

Publication number
WO2010001408A3
WO2010001408A3 PCT/IN2009/000329 IN2009000329W WO2010001408A3 WO 2010001408 A3 WO2010001408 A3 WO 2010001408A3 IN 2009000329 W IN2009000329 W IN 2009000329W WO 2010001408 A3 WO2010001408 A3 WO 2010001408A3
Authority
WO
WIPO (PCT)
Prior art keywords
polymorphic forms
gemifloxacin mesylate
mesylate
novel polymorphic
gemifloxacin
Prior art date
Application number
PCT/IN2009/000329
Other languages
French (fr)
Other versions
WO2010001408A2 (en
Inventor
Ramakoteswara Rao Jetti
Ramireddy Bommareddy Aggi
Debashish Datta
Original Assignee
Matrix Laboratories Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Laboratories Ltd. filed Critical Matrix Laboratories Ltd.
Publication of WO2010001408A2 publication Critical patent/WO2010001408A2/en
Publication of WO2010001408A3 publication Critical patent/WO2010001408A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Abstract

The present invention relates to novel crystalline forms of 1-cyclopropyl-y-chloro-ό- fluoro-4-oxo-1,4-dihydro[1,8]-naphthyridine-3-carboxylic acid mesylate salt (Gemifloxacin mesylate) hereafter designated as Gemifloxacin mesylate polymorphic Forms-H, I, J, K, L and M and process for the preparation thereof.
PCT/IN2009/000329 2008-06-06 2009-06-05 Novel polymorphic forms of gemifloxacin mesylate WO2010001408A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1382CH2008 2008-06-06
IN1382/CHE/2008 2008-06-06

Publications (2)

Publication Number Publication Date
WO2010001408A2 WO2010001408A2 (en) 2010-01-07
WO2010001408A3 true WO2010001408A3 (en) 2010-05-14

Family

ID=41466393

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2009/000329 WO2010001408A2 (en) 2008-06-06 2009-06-05 Novel polymorphic forms of gemifloxacin mesylate

Country Status (1)

Country Link
WO (1) WO2010001408A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010146594A1 (en) * 2009-06-16 2010-12-23 Hetero Research Foundation Novel polymorphs of gemifloxacin mesylate

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042705A1 (en) * 1997-03-21 1998-10-01 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
WO2008053324A1 (en) * 2006-10-31 2008-05-08 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of gemifloxacin mesylate

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998042705A1 (en) * 1997-03-21 1998-10-01 Lg Chemical Ltd. Salt of naphthyridine carboxylic acid derivative
WO2008053324A1 (en) * 2006-10-31 2008-05-08 Orchid Chemicals & Pharmaceuticals Limited An improved process for the preparation of gemifloxacin mesylate

Also Published As

Publication number Publication date
WO2010001408A2 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
WO2010141796A3 (en) PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a] PYRIDINE DERIVATIVES
WO2009079008A8 (en) Benzopyrans and analogs as rho kinase inhibitors
WO2009114181A3 (en) Substituted heterocycle fused gamma-carbolines solid
WO2010139981A3 (en) Processes for preparing crystalline forms of dasatinib
WO2011024192A3 (en) Novel polymorphs of raltegravir
WO2009104021A3 (en) Novel polymorphs and processes for their preparation
WO2010001257A3 (en) Novel solid state forms of laquinimod and its sodium salt
WO2012015999A3 (en) Process for the preparation of imatinib mesylate
WO2008140641A3 (en) Pure paliperidone and processes for preparing thereof
WO2011004402A3 (en) Improved process for the preparation of ambrisentan and novel intermediates thereof
WO2009053446A3 (en) Pregabalin intermediates and process for preparing them and pregabalin
WO2007088545A3 (en) Novel process for preparing 1-(mercaptomethyl) cyclopropaneacetic acid, a useful intermediate in the preparation of montelukast and salts thereof
EP3020704A3 (en) Crystalline polymorphs of clevidipine butyrate
WO2010079045A3 (en) Crystalline salt forms of flibanserine
WO2007108011A3 (en) Process for the preparation of highly pure donepezil
WO2009062659A3 (en) Polymorphs of enantiopure erdosteine
TW200740729A (en) Methods for preparing glutamic acid derivatives
WO2010039885A3 (en) Crystalline forms of dexlansoprazole
WO2009121710A3 (en) Process for preparing nebivolol
WO2009060297A3 (en) An improved process for the preparation of paliperidone and its intermediates
WO2010122575A3 (en) Process for the preparation of pure paliperidone
WO2008104957A3 (en) Novel polymorphic forms of milnacipran hydrochloride
WO2007072507A3 (en) Polymorphic forms of dolasetron base and processes of preparing dolasetron base, its polymorphic forms and salt thereof
WO2007143014A3 (en) Methods for preparing glutamic acid derivatives and intermediates thereof
WO2009129259A3 (en) Polymorphs of 5-(3-(ethylsulfonyl)phenyl)-3,8-dimethyl-n-(1-methylpiperidin-4-yl)-9h-pyrido[2,3-b]indole-7-carboxamide and methods of use therefor

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09773062

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09773062

Country of ref document: EP

Kind code of ref document: A2